Esther de Jong

1.0k total citations
19 papers, 777 citations indexed

About

Esther de Jong is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Esther de Jong has authored 19 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Esther de Jong's work include Pluripotent Stem Cells Research (6 papers), Biomedical Ethics and Regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Esther de Jong is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Biomedical Ethics and Regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Esther de Jong collaborates with scholars based in Netherlands, United States and Denmark. Esther de Jong's co-authors include Aldert H. Piersma, DirkJan Hijnen, Edward F. Knol, Carla A.F.M. Bruijnzeel-Koomen, Marjolein de Bruin‐Weller, Miriam Verwei, Johannes J.M. van de Sandt, Bas J. Blaauboer, Ivonne M.C.M. Rietjens and Jochem Louisse and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Journal of Immunology and Toxicology and Applied Pharmacology.

In The Last Decade

Esther de Jong

19 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther de Jong Netherlands 12 244 209 172 140 135 19 777
H.-W. Vohr Germany 16 82 0.3× 421 2.0× 350 2.0× 130 0.9× 58 0.4× 26 911
Kazuichi Nakamura Japan 12 127 0.5× 136 0.7× 83 0.5× 23 0.2× 57 0.4× 34 410
Stefan Tukaj Poland 22 446 1.8× 208 1.0× 159 0.9× 44 0.3× 60 0.4× 51 979
Carla Motta Portugal 17 294 1.2× 52 0.2× 67 0.4× 17 0.1× 132 1.0× 51 851
Leihong Xiang China 14 157 0.6× 102 0.5× 445 2.6× 33 0.2× 36 0.3× 40 740
Irving Seidman United States 13 224 0.9× 52 0.2× 84 0.5× 47 0.3× 125 0.9× 27 849
Judith G.M. Bergboer Netherlands 11 166 0.7× 354 1.7× 451 2.6× 38 0.3× 152 1.1× 15 810
Takenori Takahashi Japan 15 285 1.2× 143 0.7× 219 1.3× 15 0.1× 40 0.3× 43 642
Shan Jin China 14 216 0.9× 254 1.2× 103 0.6× 15 0.1× 63 0.5× 49 646
Rika Nakamura Japan 18 328 1.3× 231 1.1× 44 0.3× 14 0.1× 54 0.4× 46 897

Countries citing papers authored by Esther de Jong

Since Specialization
Citations

This map shows the geographic impact of Esther de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther de Jong more than expected).

Fields of papers citing papers by Esther de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther de Jong. The network helps show where Esther de Jong may publish in the future.

Co-authorship network of co-authors of Esther de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Esther de Jong. A scholar is included among the top collaborators of Esther de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther de Jong. Esther de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kruisselbrink, Johannes W., Jasper Engel, Hilko van der Voet, et al.. (2023). Standard regulatory action for retrospective cumulative risk assessment of pesticides in MCRA. EFSA Supporting Publications. 20(10). 3 indexed citations
2.
Klaveren, J.D. van, Johannes W. Kruisselbrink, Hilko van der Voet, et al.. (2023). The MCRA platform for EU regulatory actions: governance, user guidance and FAIRification. EFSA Supporting Publications. 20(10). 4 indexed citations
3.
Jong, Esther de, Hilko van der Voet, Philip Marx‐Stoelting, et al.. (2022). Roadmap for action on Risk Assessment of Combined Exposure to Multiple Chemicals (RACEMiC). EFSA Supporting Publications. 19(10). 15 indexed citations
4.
Wolterink, Gerrit, et al.. (2022). Neurodegeneration in a regulatory context: The need for speed. Current Opinion in Toxicology. 33. 100383–100383. 4 indexed citations
5.
Sengupta, S., Lijoy K. Mathew, Lisa Truong, et al.. (2019). Glucocorticoid receptor-dependent induction of cripto-1 (one-eyed pinhead) inhibits zebrafish caudal fin regeneration. Toxicology Reports. 6. 529–537. 10 indexed citations
6.
Jong, Esther de, Lianne van Beek, & Aldert H. Piersma. (2014). Comparison of osteoblast and cardiomyocyte differentiation in the embryonic stem cell test for predicting embryotoxicity in vivo. Reproductive Toxicology. 48. 62–71. 14 indexed citations
7.
Schulpen, Sjors H.W., Esther de Jong, Liset J.J. de la Fonteyne, Arja de Klerk, & Aldert H. Piersma. (2014). Distinct gene expression responses of two anticonvulsant drugs in a novel human embryonic stem cell based neural differentiation assay protocol. Toxicology in Vitro. 29(3). 449–457. 17 indexed citations
8.
Hettne, Kristina, André Boorsma, Dorien A.M. van Dartel, et al.. (2013). Next-generation text-mining mediated generation of chemical response-specific gene sets for interpretation of gene expression data. BMC Medical Genomics. 6(1). 2–2. 11 indexed citations
9.
Jong, Esther de, Lianne van Beek, & Aldert H. Piersma. (2012). Osteoblast differentiation of murine embryonic stem cells as a model to study the embryotoxic effect of compounds. Toxicology in Vitro. 26(6). 970–978. 16 indexed citations
10.
Theunissen, Peter T., Joshua F. Robinson, Jeroen L. A. Pennings, et al.. (2011). Transcriptomic Concentration-Response Evaluation of Valproic Acid, Cyproconazole, and Hexaconazole in the Neural Embryonic Stem Cell Test (ESTn). Toxicological Sciences. 125(2). 430–438. 48 indexed citations
11.
Jong, Esther de, Marta Barenys, Sanne A.B. Hermsen, et al.. (2011). Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. Toxicology and Applied Pharmacology. 253(2). 103–111. 81 indexed citations
12.
Louisse, Jochem, Esther de Jong, Johannes J.M. van de Sandt, et al.. (2010). The Use of In Vitro Toxicity Data and Physiologically Based Kinetic Modeling to Predict Dose-Response Curves for In Vivo Developmental Toxicity of Glycol Ethers in Rat and Man. Toxicological Sciences. 118(2). 470–484. 103 indexed citations
13.
Jong, Esther de, et al.. (2009). Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX®. Toxicology Letters. 186(2). 115–122. 12 indexed citations
14.
Jong, Esther de, Jochem Louisse, Miriam Verwei, et al.. (2009). Relative Developmental Toxicity of Glycol Ether Alkoxy Acid Metabolites in the Embryonic Stem Cell Test as compared with the In Vivo Potency of their Parent Compounds. Toxicological Sciences. 110(1). 117–124. 52 indexed citations
15.
Kaliński, Paweł, Eva Wieckowski, Ravikumar Muthuswamy, & Esther de Jong. (2009). Generation of Stable Th1/CTL-, Th2-, and Th17-Inducing Human Dendritic Cells. Methods in molecular biology. 595. 117–133. 20 indexed citations
16.
Boor, Patrick P.C., Jan N.M. IJzermans, Renate G. van der Molen, et al.. (2005). Immunomagnetic selection of functional dendritic cells from human lymph nodes. Immunology Letters. 99(2). 162–168. 8 indexed citations
17.
Hijnen, DirkJan, et al.. (2004). Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseases. Journal of Allergy and Clinical Immunology. 113(2). 334–340. 204 indexed citations
18.
Smits, Hermelijn H., Astrid J. van Beelen, Christina Hessle, et al.. (2004). Commensal Gram‐negative bacteria prime human dendritic cells for enhanced IL‐23 and IL‐27 expression and enhanced Th1 development. European Journal of Immunology. 34(5). 1371–1380. 154 indexed citations
19.
Kaliński, Paweł, Catharien M. U. Hilkens, Joost H. N. Schuitemaker, Esther de Jong, & Martien L. Kapsenberg. (1997). Th1- versus Th2- inducing CD1a+CD83+ dendritic cells, which mature in the absence or in the presence of PGE2. Immunology Letters. 56. 354–354. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026